🧬Chris Moxham - Transcripta Bio - Part 4 | Partnership Strategies with Big Pharma | Balancing Science & Business | Leveraging AI in Drug Discovery | The Vision for Transcripta Bio

Part 4 of 4: Jon Chee hosts Chris Moxham, Co-Founder, CEO, and CSO of Transcripta Bio—a pioneering biotech company accelerating drug discovery to improve lives worldwide.

With a PhD in Molecular and Cellular Pharmacology from Stony Brook University and over 25 years in drug discovery, Chris brings a wealth of experience. During his two-decade tenure at Eli Lilly, he advanced over 10 molecules into clinical trials across multiple therapeutic areas, spanning both small and large molecule modalities.

Chris’s deep expertise and dedication to scientific innovation and team development offer invaluable insights for aspiring biotech leaders.

Please enjoy Jon’s conversation with Chris Moxham.

https://www.linkedin.com/in/christopher-moxham-b8867011/ 

https://www.transcriptabio.com/ 

LinkedIn: https://www.linkedin.com/company/excedr/ 

Youtube: https://www.youtube.com/@excedr 

Instagram: https://www.instagram.com/excedr_inc 

Twitter: https://twitter.com/ExcedrInc 

Facebook: https://www.facebook.com/excedr 

TikTok: https://www.tiktok.com/@excedr 

Podcast Website: https://www.thebiotechstartupspodcast.com/

Eli Lilly & Company: https://www.lilly.com/

Transcripta Bio: https://www.transcriptabio.com/

Fulcrum Therapeutics: https://www.fulcrumtx.com/

NVIDIA: https://www.nvidia.com/en-us/

Biotech Partnerships with Big Pharma: https://www.excedr.com/blog/how-biotech-partnerships-support-research

The Role of BD in the Life Sciences: https://www.excedr.com/resources/business-development-in-the-life-sciences

How to Break into Biotech BD: https://www.excedr.com/blog/how-to-break-into-biotech-bd-as-a-phd-student

Drug-Gene Atlas: https://www.transcriptabio.com/what-we-do

Biotech Startup Support: https://www.excedr.com/resources-category/biotech-startup-support

Efraim Racker: https://efraimracker.library.cornell.edu/

Craig Malbon: https://www.pharm.stonybrook.edu/faculty/m/malbon

John Hadcock: https://www.linkedin.com/in/hadcock/

Alan Palkowitz: https://www.linkedin.com/in/alan-palkowitz-7387653/

Phil Hipskin: https://www.linkedin.com/in/philip-hipskind-a3b11611/

Greg Plowman: https://www.linkedin.com/in/greg-plowman-4177096/

Robert Gould: https://www.linkedin.com/in/robertjgouldfulcrum/

Jim Collins: https://be.mit.edu/faculty/james-j-collins/

Jim Geraghty: https://www.linkedin.com/in/jim-geraghty-7481a262/

Alan Ezekowitz: https://www.linkedin.com/in/alan-ezekowitz-54030515/

Dave Port: https://www.linkedin.com/in/j-david-port-ab9616b/

00:00 Intro and recap

02:09 Partnering with Big Pharma and the urgency of startups

04:13 Learning business development and building successful partnerships

06:18 Understanding stakeholder involvement and approval layers in Big Pharma

09:42 Transcripta's collaborations with patient foundations and medical institutions

11:31 Ideal partnerships with academic institutions and aligning incentives

15:53 The importance of partnership alignment, building trust within the org

20:47 Transcripta Bio's vision for the future

21:52 Shoutouts and advice to younger self

24:45 Outro

The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.